Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Merck
Dow
Boehringer Ingelheim
AstraZeneca
McKinsey
Johnson and Johnson

Last Updated: January 28, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Dapivirine

See Plans and Pricing

« Back to Dashboard

What is the drug development status for Dapivirine?

Dapivirine is an investigational drug.

There have been 40 clinical trials for Dapivirine. The most recent clinical trial was a Phase 3 trial, which was initiated on March 1st 2016.

The most common disease conditions in clinical trials are HIV Infections, Acquired Immunodeficiency Syndrome, and Infection. The leading clinical trial sponsors are International Partnership for Microbicides, Inc., National Institute of Allergy and Infectious Diseases (NIAID), and National Institutes of Health (NIH).

There are thirty US patents protecting this investigational drug and seven hundred and one international patents.

Recent Clinical Trials for Dapivirine
TitleSponsorPhase
Safety and Drug Detection Study of Dapivirine Vaginal Ring and Oral TRUVADA® in Breastfeeding Mother-Infant PairsNational Institute of Allergy and Infectious Diseases (NIAID)Phase 3
Randomized, Open Label Safety Trial of Dapivirine Vaginal Ring and Oral TRUVADA® Use in PregnancyNational Institute of Allergy and Infectious Diseases (NIAID)Phase 3
Evaluating the Safety of and Adherence to a Vaginal Matrix Ring Containing Dapivirine and Oral Emtricitabine/Tenofovir Disoproxil Fumarate in an Adolescent and Young Adult Female PopulationNational Institute of Allergy and Infectious Diseases (NIAID)Phase 2

See all Dapivirine clinical trials

Clinical Trial Summary for Dapivirine

Top disease conditions for Dapivirine
Top clinical trial sponsors for Dapivirine

See all Dapivirine clinical trials

US Patents for Dapivirine

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Dapivirine   Start Trial Combination therapy intravaginal rings International Partnership for Microbicides, Inc. (Silver Spring, MD)   Start Trial
Dapivirine   Start Trial HIV replication inhibiting pyrimidines Janssen Pharmaceutica NV (Beerse, BE)   Start Trial
Dapivirine   Start Trial HIV inhibiting pyrimidine derivative Janssen Pharmaceutica, Inc. (New Brunswick, NJ)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Dapivirine

Drugname Country Document Number Estimated Expiration Related US Patent
Dapivirine African Regional IP Organization (ARIPO) 1610 2021-08-13   Start Trial
Dapivirine African Regional IP Organization (ARIPO) 2109 2021-08-13   Start Trial
Dapivirine African Regional IP Organization (ARIPO) 2296 2021-08-13   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Merck
McKesson
Mallinckrodt
AstraZeneca
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.